Chimerocyte

Curated by Signal

Cancer data visualization and analysis tool for drug development

Overview

Cancer data visualization and analysis tool for drug development. The company has developed a platform that enables users to detect and quantify allogeneic cells and DNA. It has features for real-time quantitative PCR, relapse probability information management, and clinical workflow management.

Key facts

Founded: 2017
Headquarters: Seattle, United States
Stage: Sign up to view
Industry: Health Technology

Contact

Email: Sign up to view

More on Vanberra Signal

Members only

Business overviewCore metrics and financials PeopleLeadership and key people Similar companiesPeers and competitors Deep AnalysisAI-generated strategic report

Competitors & similar companies

More Health Technology companies

Cress Health
Provider of digital platform to assist individuals to enhance mental wellness
Health TechnologyNew York City, United States
BaxRx
Provider of discounts on prescription medications at pharmacies
Health TechnologySaint Michael, United States
PursueCare
Mobile app offering addiction treatment
Health TechnologyMiddletown, United States

About Chimerocyte

What does Chimerocyte do?

Cancer data visualization and analysis tool for drug development.

Where is Chimerocyte headquartered?

Chimerocyte is headquartered in Seattle, United States.

When was Chimerocyte founded?

Chimerocyte was founded in 2017.

Which sector is Chimerocyte in?

Chimerocyte operates in Health Technology.

Who are Chimerocyte's competitors?

Companies similar to Chimerocyte include Cress Health, BaxRx, and PursueCare.